Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The effect of clonidine withdrawal on total 3-methoxy-4-hydroxyphenylglycol in the rat brain

  • 9 Accesses

  • 11 Citations


The effect of clonidine withdrawal on the brain norepinephrine system was studied in the rat. Clonidine suppresses brain total 3-methoxy-4-hydroxyphenylglycol (MHPG) significantly and no tolerance to this effect was observed up to 21 days. Cessation of clonidine treatment resulted in an elevation in the level of brain total MHPG. The suitability of the clonidine withdrawal syndrome as a model of bipolar depression is discussed.

This is a preview of subscription content, log in to check access.


  1. Bond, P. A., Jenner, F. A., Sampson, G. A.: Daily variations of the urine content of MHPG in two manic-depressive patients. Psychol. Med. 2, 81–85 (1972)

  2. Greenspan, K., Schildkraut, J. J., Gordon, E. K., Baer, L., Aronoff, M. D., Durell, J.: Catecholamine metabolism in affective disorders III. J. Psychiat. Res. 7, 171–183 (1970)

  3. Hansson, L., Hunyor, M., Julius, S., Hoobler, S.: Blood pressure crisis following withdrawal of clonidine (Catapress, Catapresan) with specific reference to arterial and urinary catecholamine levels and suggestions for acute management. Amer. Heart J. 85, 605–610 (1973)

  4. Hokfelt, B., Hedeland, H., Dymling, J. F.: Studies on catecholamines, renin and aldosterone following catapresan [2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride] in hypertensive patients. Eur. J. Pharmacol. 10, 389–397 (1970)

  5. Jones, F. D., Maas, J. W., Dekirmenjian, H., Fawcett, J. A.: Urinary catecholamines during behavioral changes in a patient with manic-depressive cycles. Science 179, 200–202 (1973)

  6. Maas, J. W., Fawcett, J., Dekirmenjian, H.: 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depressive states. Arch. Gen. Psychiatry 19, 129–134 (1968)

  7. Schildkraut, J. J.: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 122, 509–522 (1965)

  8. Simpson, F. O.: Hypertension and depression: interrelated problems in therapy. J. R. Coll. Physicians London 6, 14–24 (1971)

  9. Svensson, T. H., Strömbom, U.: Discontinuation of chronic clonidine treatment: evidence for facilitated brain noradrenergic neurotransmission. Naunyn-Schmiedeberg's Arch. Pharmacol. 299, 83–87 (1977)

  10. Takahashi, S., Godse, D. D., Warsh, J. J., Stancer, H. C.: A gas chromatographic-mass spectrometric (GS-MS) assay for 3-methoxy-4-hydroxyphenethyleneglycol and vanilmandelic acid in human serum. Clin. Chim. Acta 81, 183–192 (1977)

Download references

Author information

Correspondence to Harvey C. Stancer.

Additional information

Ontario Mental Health Foundation Research Fellow 1977–1978

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tang, S.W., Helmeste, D.M. & Stancer, H.C. The effect of clonidine withdrawal on total 3-methoxy-4-hydroxyphenylglycol in the rat brain. Psychopharmacology 61, 11–12 (1979). https://doi.org/10.1007/BF00426802

Download citation

Key words

  • Clonidine
  • Brain 3-methoxy-4-hydroxyphenylglycol
  • Withdrawal syndrome
  • Rat
  • Bipolar depression